文献速递焦虑、强迫与应激相关障碍

焦虑障碍中皮质含胆碱化合物的跨诊断性降低:一项1H-MRS荟萃分析

Transdiagnostic reduction in cortical choline-containing compounds in anxiety disorders: a 1H-magnetic resonance spectroscopy meta-analysis.
PubMed 文献 · Mol Psychiatry · 2025-09-05

该系统综述与荟萃分析纳入25个1H-MRS数据集,比较370例焦虑障碍患者与342名对照的神经代谢物。结果显示皮质总胆碱(tCho)显著降低(Hedges' g=-0.64,平均降低8%),前额叶皮质tCho亦降低;全皮质NAA减少,其他代谢物无显著差异。异常在社交焦虑障碍、广泛性焦虑障碍和惊恐障碍间无差异。

要点

  • 焦虑障碍患者皮质tCho显著降低,效应量Hedges' g=-0.64,平均降低8%。
  • 全皮质NAA减少提示神经元功能受损,但前额叶皮质NAA无变化。
  • tCho与NAA异常在三种焦虑障碍间无差异,呈跨诊断特征。

核心结论

  • 皮质含胆碱化合物降低是焦虑障碍跨诊断的一致异常。
  • 皮质NAA降低提示焦虑障碍存在神经元功能受损。
  • 慢性觉醒升高可能增加胆碱需求而不成比例增加脑摄取,导致tCho降低。

研究设计与样本

  • 系统综述与荟萃分析纳入25个已发表的1H-MRS数据集。
  • 比较370例焦虑障碍患者(社交焦虑障碍、广泛性焦虑障碍、惊恐障碍)与342名对照。
  • 分析代谢物包括NAA、总肌酸、tCho、肌醇、谷氨酸、谷氨酸+谷氨酰胺、GABA和乳酸。

主要发现

  • 前额叶皮质及全皮质tCho显著降低,测量质量更好的研究效应量更负(Hedges' g=-0.64,平均降低8%)。
  • 前额叶皮质NAA无变化,全皮质NAA在排除后减少。
  • 上述异常在三种焦虑障碍间无差异,其他神经代谢物无显著差异。

关键数值与推荐

  • 皮质tCho效应量Hedges' g=-0.64,平均降低8%。

临床怎么用

  • 皮质tCho降低可作为焦虑障碍跨诊断的神经代谢标志物参考。
  • 未来研究可探索适当补充胆碱对焦虑障碍的治疗获益。

局限性

  • 原文未明确报告纳入研究的其他方法学局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anxiety disorders (AnxDs) are highly prevalent and often untreated or unresponsive to treatment. Although proton magnetic resonance spectroscopy (1H-MRS) studies of AnxDs have been conducted for over 25 years, a consensus regarding neurometabolic abnormalities in these conditions is lacking. METHODS: A systematic review and meta-analysis of 1H-MRS studies of AnxDs (social anxiety disorder, generalized anxiety disorder, and panic disorder) identified 25 published datasets meeting inclusion criteria. These compared neurometabolites between 370 patients and 342 controls, including n-acetlyaspartate (NAA), total creatine, total choline (tCho), myo-inositol, glutamate, glutamate+glutamine, GABA, and lactate. RESULTS: Across AnxDs, tCho was significantly reduced in prefrontal cortex and across all cortical regions. Effect sizes for cortical tCho were significantly more negative in studies with better measurement quality, with Hedges' g = -0.64 and an 8% mean reduction. NAA was unchanged in prefrontal cortex but reduced across all cortical regions (after exclusions). These abnormalities did not differ between the three disorders. No other neurometabolites differed significantly. DISCUSSION: Reduced choline-containing compounds in cortical regions is a consistent, transdiagnostic abnormality in AnxDs. Notably, arousal-related neuromodulators, including norepinephrine, alter membrane phospholipid homeostasis and methylation reactions, which influence brain tCho levels. This suggests that chronically elevated arousal in AnxDs may increase neurometabolic demand for choline compounds without a proportionate increase in brain uptake, leading to reduced tCho levels. Reduced cortical NAA suggests compromised neuronal function in AnxDs. Future studies may clarify the clinical significance of reduced cortical tCho and the possibility that appropriate choline supplementation could have therapeutic benefit in anxiety disorders.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Maddock RJ, Smucny J. Transdiagnostic reduction in cortical choline-containing compounds in anxiety disorders: a 1H-magnetic resonance spectroscopy meta-analysis. Mol Psychiatry. 2025. PMID: 40913113. doi:10.1038/s41380-025-03206-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。